Mass tort marketing is the machinery a law firm builds to reach, screen and sign people harmed by the same drug, device or event, at a scale where the claims usually end up in a multidistrict litigation.
It sits at the high-risk end of personal injury marketing: a smaller pool of prospective clients, a case supply that arrives in waves and then stops, and advertising statutes some states write specifically for these campaigns.
How mass tort marketing works: MDLs set the rhythm
Mass tort demand is created by litigation events, not by evergreen search habits: the wave of claimants grows while a case is being recruited and shrinks after a settlement or verdict.
The federal numbers show both the scale and the stop: the Judicial Panel on Multidistrict Litigation acted on 37,735 civil actions and created 19 new MDL dockets in fiscal 2025, and 197,118 actions were pending in MDLs at year end (U.S. Courts, Judicial Business 2025).
The same report shows a wave closing: pending federal civil cases fell 19% to 432,923 in fiscal 2025, with most of the drop coming from personal injury and product liability cases in the Northern District of Florida as the 3M earplug MDL cases closed (U.S. Courts, Judicial Business 2025).
That makes a mass tort practice a series of windows: the docket opens, claimants seek counsel, and the channel either finds the next litigation or shrinks back to ordinary injury work.
An MDL is not a class action, although some MDLs include class claims, and class action marketing is its own topic with its own rules questions.
Where mass tort leads come from
Mass tort leads start as attention rather than intent: a person with a drug injury may not connect the drug to the injury until an ad or a news story suggests it.
That attention is manufactured through television campaigns, paid social, search ads built on drug and device names, and lead sellers who run their own campaigns and route inquiries to firms.
Who buys them: plaintiff firms that take the cases on contingency, with the fee set out in a signed writing (ABA Model Rule 1.5(c) requires a contingent fee agreement in a writing signed by the client, stating the percentages and the expense terms; your state's rule controls).
Say a campaign produces 100 inquiries in a month, 30 of those people report an injury and exposure history that fit the case criteria, and 12 go on to sign.
The mass tort screening funnel
The screening step is the economics of the channel: a signed case that costs more than its expected fee is a loss, which is why the channel is judged on cost per signed case rather than cost per lead.
The mechanics of buying injury leads, what vendors publish and how to compare them are in personal injury leads; what follows is what is specific to mass tort.
Paying for mass tort lead generation: what the ethics rules say
The anchor is ABA Model Rule 7.2's Comment [5], which says a lawyer may pay a lead generator only if the generator does not recommend the lawyer, the payment is consistent with Rules 1.5(e) and 5.4, and the generator's communications are consistent with Rule 7.1; Model Rules bind no one until a state adopts them, so your state's version controls.
The same comment bars paying a generator that implies it is recommending you, implies it refers people without being paid, or implies it analyzed the person's legal problem to pick the lawyer, and "we'll review your case and connect you with the right attorney" is the textbook version of the third.
ABA Formal Opinion 501 (April 13, 2022) shows how the vendor's conduct becomes the firm's: a lawyer paying a flat monthly fee for mass tort leads kept accepting clients the generator found by phoning people in online accident-survivor chat rooms, and the opinion concluded the lawyer was responsible for prohibited solicitation and violated Rules 5.3(b) and 5.3(c) by failing to train the vendor and ratifying its conduct.
The opinion also notes that a conscious failure to inquire can count as knowledge; ABA ethics opinions are advisory, not binding in any state.
Because much of this lead generation runs on calls and texts, the TCPA applies here too: the 11th Circuit vacated the FCC's 2023 one-to-one consent requirements on January 24, 2025, and the current federal text (47 CFR 64.1200, as of October 1, 2026) still requires prior express written consent for telemarketing robocalls and robotexts made with an autodialer or an artificial or prerecorded voice, with no one-seller-at-a-time condition.
State mini-TCPA laws can be stricter (Florida's is one example), and 2024-era guidance presenting the one-to-one rule as still coming is out of date.
The full treatment of lead buying and referral fees is in lead generation ethics for lawyers, and the advertising framework underneath is in lawyer advertising rules.
What mass tort advertising statutes say
Texas and West Virginia have statutes written specifically about legal advertising for drug and device cases.
In Texas, Government Code chapter 81, subchapter J (added by SB 1189, effective September 1, 2019) applies to television advertisements that promote legal services or solicit clients, and the statute is written for TV, so it does not reach online ads on its own terms.
Section 81.152 bars ads dressed up as editorial: a legal TV ad may not be presented as a "medical alert," "health alert," "drug alert" or "public service announcement," or similar.
Section 81.153(a) requires the ad to state verbally and visually at the start that "This is a paid advertisement for legal services.", identify the sponsor, and identify the responsible lawyer or firm or how cases are referred (that last prong targets non-lawyer sponsors).
Section 81.153(b) requires ads soliciting people injured by an FDA-approved prescription drug to say, verbally and visually, "Do not stop taking a prescribed medication without first consulting a physician."
Section 81.155 makes violations deceptive acts enforceable only by the Texas attorney general's consumer protection division or district and county attorneys, with no private action, and it limits enforcement where the State Bar of Texas advertising review committee approved the ad beforehand (the statute refers ads to that committee for review before first dissemination, section 81.155(c)), subject to conditions, so pre-approval is not blanket immunity.
West Virginia's counterpart is Code § 47-28-3 (enacted 2020, SB 136): legal ads about prescription drugs or devices must carry the paid-advertisement disclosure, a do-not-stop-medication warning, and a statement that the product remains FDA-approved unless it has been recalled or withdrawn.
Texas: Government Code ch. 81, subch. J
- Applies to television ads promoting legal services or soliciting clients (SB 1189, effective Sept. 1, 2019)
- No "medical alert," "health alert," "drug alert" or "public service announcement" framing (§ 81.152)
- Opening disclosure "This is a paid advertisement for legal services.", sponsor identity, and responsible lawyer or referral disclosure, spoken and on screen (§ 81.153(a))
- Do-not-stop-medication warning in prescription-drug ads (§ 81.153(b))
- Enforced by the state AG and district or county attorneys; bar pre-review limits enforcement (§ 81.155)
West Virginia: Code § 47-28-3
- Covers legal ads about prescription drugs or devices (enacted 2020, SB 136)
- Requires the paid-advertisement disclosure
- Requires a do-not-stop-medication warning
- Requires a statement that the product remains FDA-approved unless recalled or withdrawn
Neither statute is a template for the rest of the country or for online ads: your own state's rules control.
More Booked Cases does not run TV campaigns and does not sell leads: the work here is CRO on websites and landing pages, local SEO, and managed Meta ads, judged by consultations and signed cases.
Mass tort lawyer SEO
Mass tort lawyer SEO is a contest over drug names, device names and injury symptoms: a page that explains the product, the alleged injury, the litigation's current stage and who qualifies answers the questions a prospective client and their family actually type.
The window problem applies here too: rankings built around one drug name stop paying when the litigation ends, so build on a general personal injury lawyer SEO foundation and layer case pages on top.
One check belongs on every page: ABA Model Rule 7.1 prohibits false or misleading communications about a lawyer or the lawyer's services, and its first comment says it governs all communications about services, including advertising; your state's version controls.
What to measure
The chain is short: inquiries, screened consultations, signed retainers, then the litigation itself.
Cost per signed case is the number that puts a TV campaign, a lead seller and a search campaign on one footing, and the arithmetic with a worked example is in cost per signed case.
No published benchmark exists for the rate in the middle of the funnel, and consultation to signed case rate shows how to measure your own.
Before a campaign spends, five questions:
- Is the litigation active, and what stage is it in?
- What are the case criteria in writing: injury, exposure, timing, exclusions?
- Who answers the phone and the form, and how fast?
- What will each signed case have cost by the end?
- Which disclosure and review requirements apply in every state where the ads will run?
Nothing here is legal advice: the rules above are described as written, and before you spend, confirm what your state requires with your state bar's ethics counsel or an ethics lawyer.
Frequently asked questions
What does mass tort mean?
Many people harmed the same way by the same product, drug, device or event, whose claims are pursued in bulk instead of one lawsuit at a time. The claims are often coordinated in a multidistrict litigation, but mass tort and MDL are not synonyms.
Is an MDL the same as a class action?
No. An MDL is not a class action, although some MDLs include class claims, so treat the two separately.
How do law firms get mass tort leads?
Television campaigns, paid social, search ads built on drug and device names, and lead sellers that generate inquiries and route them to firms. ABA Model Rule 7.2's Comment [5] sets the conditions for paying a generator, and your state's version of the rule controls.
What are the four major kinds of mass torts?
Lists vary, and federal MDL categories are not a list of mass torts: of the 19 new MDLs the JPML created in fiscal 2025, 6 involved data breach and consumer privacy, 5 intellectual property, 3 antitrust, 2 products liability, 2 marketing and sales practices, and 1 an air disaster (U.S. Courts, Judicial Business 2025). Intellectual property and antitrust dockets are not injury claims, so only part of that spread is mass tort work.
How much is a mass tort settlement?
We have no verified national figure to quote: outcomes are decided claim by claim and turn on the injury, the proof and how the litigation resolves. Treat any dollar figure in a mass tort ad as the advertiser's estimate, not a valuation.
Does federal law still require one-to-one consent for lead forms?
No: the 11th Circuit vacated the FCC's one-to-one consent rule on January 24, 2025. The current federal text (47 CFR 64.1200, as of October 1, 2026) still requires prior express written consent for telemarketing calls and texts made with an autodialer or an artificial or prerecorded voice, and state laws can be stricter.